Delivery Order SPE2DB24D3013-SPE2DB24FFGNX

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lyrica 75 mg capsules. The contract has a ceiling value of $2,693.45 and is a firm fixed-price delivery order with an ultimate completion date of April 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 150mg capsules. The contract has a ceiling value of $2,939.05 and a period of performance through September 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,812.70, is for the supply of Lyrica 75 mg capsules. The contract has an ultimate completion date of August 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,736.28 firm-fixed-price contract is for the supply of Lyrica 75 mg capsules. The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of a prescription medication, Lyrica 150 mg capsules. The contract has a ceiling value of $3,817.98 and a performance period ending on September 19, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lyrica 150 mg capsules. The contract has a firm fixed price of $3,459.54 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a $6,754.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lyrica 75 mg capsules and has a period of performance through March 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 75 mg capsules. The fixed-price contract has an ultimate completion date of July 30, 2024 and a ceiling value of $2,713.64. The award is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,877.62, is for the delivery of Lyrica 300 mg capsules. The contract is a firm fixed-price delivery order, with a period of performance through March 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,133.45, is for the supply of 4,565,938,887 units of Lyrica 75 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of September 26, 2024. It is not a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGNX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 75 mg capsules. The contract has a firm fixed price of $1,616.07 and a performance period through August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 10/30/24, 9:36 AM